StockMarketWire.com - Sensyne Health identified IT services provider Cognizant and data infrastructure specialist Agorai as its partners for the launch and sale of its digital health software products in the US.

The company had announced last month that it had signed agreements, but without naming the parties.

'Cognizant and Agorai are excellent partners that will enable us to ensure that the full potential of these innovative products, first invented in the UK's NHS, is realised in the US market,' chief executive Paul Drayson said.

'Following the appropriate regulatory approvals, Cognizant will provide these digital health applications to US health care providers and the commercial return made by Sensyne will be shared with the NHS.'


At 9:23am: [LON:SENS] Sensyne Health Plc Ord 10p share price was +2.5p at 102.5p



Story provided by StockMarketWire.com